Michael Greve

Greve has a clear and publicly stated longevity vision centered on a world without age-related diseases and vastly extending healthy lifespan. The evidence shows ambition, durability through Forever Healthy and Kizoo, and some concrete pathway language around prevention, evidence reviews, ecosystem-building, and translation of molecular repair research into therapies. The score is not higher because the evidence does not include detailed personal theory endorsements, timelines, or a highly specific roadmap attributed directly to Greve.

Evidence for scientific impact is sparse and indirect. There are no citation metrics, authored papers, clinical trials, or independently corroborated scientific outputs. The available evidence supports that Greve enabled longevity and rejuvenation efforts through Forever Healthy and Kizoo, but does not demonstrate field-shaping scientific influence or direct technical contributions.

Capital deployment is applicable because the evidence describes Greve as operating Forever Healthy and Kizoo in longevity/rejuvenation biotech, but the record provided contains no disclosed investment or donation amounts, no named portfolio companies or grants, and no primary/independent corroboration of actual capital deployed. The score is therefore capped and confidence is low despite plausible institution-building signals.

The dimension applies because Greve has public longevity deployment activity through Forever Healthy and Kizoo-linked rejuvenation biotech work. The evidence shows a coherent thesis: combine practical near-term health optimization with translation of molecular repair and rejuvenation research into human therapies. That supports moderate strategic taste, especially for thesis coherence and translational focus. However, the evidence is mostly self-published, lacks dates, disclosed investments, stage choices, counterfactual detail, or proof that his bets opened paths others were not seeing, so the score should not be high.

Field creation applies: the evidence supports that Michael Greve founded Forever Healthy, an active longevity-focused organization with initiatives around healthy lifespan extension, intervention reviews, and translation of rejuvenation research. However, the strongest operational and field-building claims come from self-published or unknown-independence sources, so the independence gate prevents a score above 5 without primary or independent corroboration of the achievement or impact.

Greve shows clear bravery/conviction through a substantial pivot from internet entrepreneurship into longevity and rejuvenation biotech, including personal capital deployment, Kizoo investing, and founding Forever Healthy. The evidence supports career sacrifice and magnitude-relative-to-capacity, but does not establish field-defining public risk, sustained criticism, contrarian advocacy under pressure, or personal biological risk-taking.

The dimension applies because Greve is presented as founding Forever Healthy and using it for longevity ecosystem-building, evidence reviews, and translational support. However, the only concrete operational evidence is self-published or unknown-independence, and there is no independent corroboration of measurable second-order outcomes such as attracting outside capital, founders, policy attention, major collaborators, or follow-on projects. Under the independence gate, this supports a modest score but not above 5.